Shades of grey: the conundrum of implantable defibrillators in individuals with advanced CKD

about

Shades of grey: the conundrum of implantable defibrillators in individuals with advanced CKD

Item

http://www.wikidata.org/entity/Q42362485

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Shades of grey: the conundrum ...... individuals with advanced CKD

@en

Shades of grey: the conundrum ...... individuals with advanced CKD

@nl

type

Item

label

Shades of grey: the conundrum ...... individuals with advanced CKD

@en

Shades of grey: the conundrum ...... individuals with advanced CKD

@nl

prefLabel

Shades of grey: the conundrum ...... individuals with advanced CKD

@en

Shades of grey: the conundrum ...... individuals with advanced CKD

@nl

P1476

Shades of grey: the conundrum ...... individuals with advanced CKD

@en

P2093

Aisha Khattak

http://www.w3.org/2001/XMLSchema#string

P2860

Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials.

A meta-analysis of mortality in end-stage renal disease patients receiving implantable cardioverter defibrillators (ICDs).

Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidney disease.

The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease

Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease.

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease.

P304

1107-1109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.2215/CJN.05340515

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David M Charytan

P577

2015-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26111858

http://www.w3.org/2001/XMLSchema#string

P921

defibrillator

P932

4491286

http://www.w3.org/2001/XMLSchema#string